Effects of Dapagliflozin Treatment on Urinary Proteomic Patterns in Patients With Type 2 Diabetes
Clinical trial NCT02914691 · COMPLETED
Trial details
- NCT number
- NCT02914691
- Sponsor
- Peter Rossing
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2017-07-05
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.